And other biotech news, brought to you by The Readout newsletter
Espace publicitaire · 300×250
STAT+: Novo strikes deal for diabetes cell therapies
STAT | Reporting from the frontiers of health and medicine • Publié le 21 janvier 2026
Espace publicitaire · 728×90
Articles similaires
🇬🇧 → 🇫🇷
What one CDC official calls ‘the cost of doing business’
And other health news from Morning Rounds today
🇬🇧 → 🇫🇷
STAT+: FDA clears Aidoc tool to detect 14 different conditions from a CT scan
FDA cleared an AI tool from Aidoc that can detect multiple conditions from a single CT scan.
🇬🇧 → 🇫🇷
STAT+: Pharmalittle: We’re reading about Canada speeding drug reviews, Novo Nordisk ads, and more
Health Canada is planning to speed up reviews of some drugs by piggybacking on the decisions of foreign regulators, including possibly the U.S. FDA
🇬🇧 → 🇫🇷
STAT+: Former Humana CEO Bruce Broussard on WISeR, AI, and transparency
In this edition of AI Prognosis: An interview with former CEO of health insurer Humana, and health AI news you need to know.
🇬🇧 → 🇫🇷
As U.S. prepares to exit WHO, it is stiffing the agency on a large bill
When the U.S. withdrawal from the WHO goes into effect Thursday, the world’s largest economy will be leaving the global health agency with a hefty unpaid bill.
🇬🇧 → 🇫🇷
STAT+: OpenEvidence raises $250 million, doubling its valuation
OpenEvidence, maker of a popular chatbot that helps doctors search clinical evidence, has raised $250 million in new funding.
🇬🇧 → 🇫🇷
Opinion: I’m getting the HPV vaccine at 24. That’s a problem
This writer is 24, in medical school — and is only now getting the HPV vaccine. The system failed her, she says.